AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
215.05
+1.93 (0.91%)
May 27, 2026, 1:45 PM EDT - Market open
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 |
|---|
| 10.97B | | | | | | | | | | | | | | | | | | | | | | | |
United States Revenue Growth | 9.92% | | | | | | | | | | | | | | | | | | | | | | | |
| 4.03B | | | | | | | | | | | | | | | | | | | | | | | |
International Revenue Growth | 19.89% | | | | | | | | | | | | | | | | | | | | | | | |
| 15.00B | | | | | | | | | | | | | | | | | | | | | | | |
| 12.43% | | | | | | | | | | | | | | | | | | | | | | | |
Revenue
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 |
|---|
| 7.29B | | | | | | | | | | | | | | | | | | | | | | | |
Immunology Revenue Growth | 16.38% | | | | | | | | | | | | | | | | | | | | | | | |
| 2.88B | | | | | | | | | | | | | | | | | | | | | | | |
Neuroscience Revenue Growth | 25.99% | | | | | | | | | | | | | | | | | | | | | | | |
| 1.63B | | | | | | | | | | | | | | | | | | | | | | | |
| -0.12% | | | | | | | | | | | | | | | | | | | | | | | |
| 1.19B | | | | | | | | | | | | | | | | | | | | | | | |
Aesthetics Revenue Growth | 7.62% | | | | | | | | | | | | | | | | | | | | | | | |
Other Key Products Revenue | 995.00M | | | | | | | | | | | | | | | | | | | | | | | |
Other Key Products Revenue Growth | 22.99% | | | | | | | | | | | | | | | | | | | | | | | |
| 1.03B | | | | | | | | | | | | | | | | | | | | | | | |
| 37.22% | | | | | | | | | | | | | | | | | | | | | | | |
| 15.00B | | | | | | | | | | | | | | | | | | | | | | | |
| 12.43% | | | | | | | | | | | | | | | | | | | | | | | |
Updated May 8, 2026. Data Source:
Fiscal.ai.
